Tags

Type your tag names separated by a space and hit enter

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals.
Lancet. 2021 03 20; 397(10279):1057-1058.Lct

Authors+Show Affiliations

Institute of Cardiovascular Science, University College London, London, UK; Department of Cardiology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.National Infection Service, Public Health England, Porton Down, UK.Institute of Cardiovascular Science, University College London, London, UK; Department of Cardiology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.The Blizard Institute, Queen Mary University of London School of Medicine and Dentistry, London, UK.Department of Immunology and Inflammation, Imperial College London, London W12 0NN, UK.National Infection Service, Public Health England, Porton Down, UK.Division of Infection and Immunity, University College London, London, UK.Department of Infectious Disease, Imperial College London, London W12 0NN, UK; Lung Division, Royal Brompton and Harefield Hospitals, London, UK. Electronic address: r.boyton@imperial.ac.uk.National Infection Service, Public Health England, Porton Down, UK.Institute of Cardiovascular Science, University College London, London, UK; Department of Cardiology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.

Pub Type(s)

Letter

Language

eng

PubMed ID

33640038

Citation

Manisty, Charlotte, et al. "Antibody Response to First BNT162b2 Dose in Previously SARS-CoV-2-infected Individuals." Lancet (London, England), vol. 397, no. 10279, 2021, pp. 1057-1058.
Manisty C, Otter AD, Treibel TA, et al. Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals. Lancet. 2021;397(10279):1057-1058.
Manisty, C., Otter, A. D., Treibel, T. A., McKnight, Á., Altmann, D. M., Brooks, T., Noursadeghi, M., Boyton, R. J., Semper, A., & Moon, J. C. (2021). Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals. Lancet (London, England), 397(10279), 1057-1058. https://doi.org/10.1016/S0140-6736(21)00501-8
Manisty C, et al. Antibody Response to First BNT162b2 Dose in Previously SARS-CoV-2-infected Individuals. Lancet. 2021 03 20;397(10279):1057-1058. PubMed PMID: 33640038.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals. AU - Manisty,Charlotte, AU - Otter,Ashley D, AU - Treibel,Thomas A, AU - McKnight,Áine, AU - Altmann,Daniel M, AU - Brooks,Timothy, AU - Noursadeghi,Mahdad, AU - Boyton,Rosemary J, AU - Semper,Amanda, AU - Moon,James C, Y1 - 2021/02/25/ PY - 2021/02/02/received PY - 2021/02/12/revised PY - 2021/02/18/accepted PY - 2021/3/1/pubmed PY - 2021/3/30/medline PY - 2021/2/28/entrez SP - 1057 EP - 1058 JF - Lancet (London, England) JO - Lancet VL - 397 IS - 10279 SN - 1474-547X UR - https://www.unboundmedicine.com/medline/citation/33640038/Antibody_response_to_first_BNT162b2_dose_in_previously_SARS_CoV_2_infected_individuals_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(21)00501-8 DB - PRIME DP - Unbound Medicine ER -